Stock Events

Lineage Cell Therapeutics (LCTX) Q4 2023 Earnings

LCTX -1.74%
7MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.04
-0.04
-0.03
-0.03

Details

Expected EPS
-0.042857
Actual EPS
-0.03
Surprise EPS
0.01
Surprise Percent
+30%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of -0.03 per share for Q4 2023.

0 Comments

Share your thoughts